This study has demonstrated that SHP is a transcriptional repressor of H19, and overexpression of SHP and knockdown of H19 attenuated Bcl2-induced cholestatic liver injury in vivo, suggesting the association of H19 with SHP expression and cholestatic liver diseases (16). The gene discussed is H19; the disease is medical procedure.